Josh Seidenfeld

Cooley advised Decagon, an innovator in conversational artificial intelligence agents for customer experience, on its $131 million Series C financing round, pushing its total funding to $231 million.

Cooley advised Meter, a provider of internet infrastructure solutions for the enterprise, on its $170 million Series C financing round.

Cooley advised FERMÀT, an artificial intelligence-native commerce platform generating brands’ shopping experiences for stronger engagement and conversion, on its $45 million Series B financing round.

Cooley advised Rillet, an artificial intelligence-native enterprise resource planning platform, on its $25 million Series A financing round.

Cooley advised HAYA Therapeutics, a biotechnology company pioneering precision RNA-guided regulatory genome-targeting therapeutics, on its $65 million Series A financing round. The round was led by Sofinnova Partners and Earlybird Venture Capital, with participation from Eli Lilly and Company, ATHOS, +ND Capital, Alexandria Venture Investments, and LifeLink Ventures, with additional support from existing investors Apollo Health Ventures, Longview Ventures (an affiliate of Broadview Ventures), 4see ventures, BERNINA Bioinvest and Schroders Capital.

Lawyers Danielle Gershowitz, Josh Seidenfeld, Amanda Gonzalez Burton, Kristine Kevorkova and Thomas Heiser led the Cooley team advising HAYA Therapeutics.